Correlation Between UGT1A1 Gene Polymorphisms and Toxicity and Efficacy in Patients with Metastatic Colorectal Cancer Treated with Irinotecan Based Chemotherapy

Rui‐Hua Xu

2012-01-01

Chinese Clinical Oncology

Abstract:Objective To analyze the distribution of UDP-glucuronosyltransferase1A1(UGT1A1) gene polymorphisms in Chinese Han patients with metastatic colorectal cancer(mCRC),and to evaluate correlations between UGT1A1 gene polymorphisms and toxicity and efficacy of irinotecan(CPT-11) combined with fluorouracil(5-FU) regimen in patients with mCRC.Methods Chinese Han patients with mCRC in the multicenter phase Ⅱ study were treated with FOLFIRI regimen(CPT-11 180mg/m2 iv)and IFL regimen(CPT-11 125mg/m2 iv).UGT1A1*28 and UGT1A1*6 genotypes were determined by direct sequencing.Effect of UGT1A1 gene polymorphisms on toxicity,efficacy and survival of chemotherapy were analyzed.Results A total of 192 patients were enrolled,and 189 patients were detected UGT1A1 gene polymorphisms.The rates of wild type,unit point mutation and two points mutation of UGT1A1 were 37.6%,43.9% and 18.5%.Treatment options included FOLFIRI or IFL regimens.One hundred and eighty-three cases were eligible for toxicity evaluation,incidence of grade 3-4 neutropenia was 26.6%(51/183),and grade 3-4 late diarrhea rate was 15.1%(29/183).Patients with two points mutation had significantly higher incidence of grade 3-4 late diarrhea than patients with wild type(26.5% vs.9.0%,P=0.021).Grade 2-4 late diarrhea rates of UGT1A1*28 wide type,UGT1A1*28 heterozygote and UGT1A1*28 homozygous were 29.6%,37.5% and 88.9%,showing significant differences(P0.05).Grade 4 neutropenia rate of UGT1A1*28 homozygous was higher than that of UGT1A1*28 wide type(33.3% vs.9.6%),with no significant difference(P=0.07).Additionally,poor ECOG status and higher dose intensity of CPT-11 also significantly increased irinotecan-related toxicity.One hundred and fifty-eight patients were evaluatable for efficacy and response rate was 20.9%.Better response rate was found in patients with two points mutation of UGT1A1 compared with wild type of UGT1A1(33.3% vs.15.3%),with no significant difference(P=0.063).Multiple regression analysis showed treatment duration has a significant impact on treatment outcomes.Less than 6 weeks treatment had significantly increased risk of disease progression(OR=6.106,95%CI: 1.680-22.197,P=0.006).Prognostic factors were ECOG status,treatment duration and regimens,but not UGT1A1 gene polymorphisms.Conclusion Chinese Han mCRC patients with two points mutation of UGT1A1 were associated with higher incidence of irinotecan-related toxicity and better response,but treatment duration shortened due to toxicity might impair the efficacy,and it is worth further investigation.